Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Novartis presents new IOP-lowering agents in recent patent

Oct. 10, 2003

Improved vision observed in phase I/II trial of squalamine in wet AMD

Oct. 9, 2003

Integrin antagonists useful for angiogenesis-related ocular diseases

Sep. 30, 2003

FDA accepts for filing diquafosol NDA for dry eye

Sep. 15, 2003

EntreMed grants Oxford BioMedica gene rights for ophthalmic applications

Sep. 12, 2003

Good efficacy and safety profile described for ranibizumab in AMD

Sep. 3, 2003

Intravitreous hyaluronidase effective in reducing vitreous hemorrhage density

Sep. 3, 2003

VEGF Trap prevents blinding blood vessel growth in mice

Aug. 28, 2003

Improved vision in extension phase of Lucentis wet AMD study

Aug. 27, 2003

Priority review for Vitrase NDA

Aug. 25, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...